Biostatistics and Programmming Case Study

Case Study Introduction

Having a number of clinical trials running at any one time can put even the most skilled internal teams under pressure, leading more and more companies to turn to experienced outsourcing partners to keep up the pace.

Outsourcing your clinical data to a clinical research organization (CRO), such as Quanticate, can help to increase the efficiency of your data management, reduce overall trial costs and add an extra layer of objective quality control.

The case study below outlines a specific example of how Quanticate has helped a ‘Top 5’ Pharmaceutical company by operating as an extension of its internal clinical team under an FSP agreement, to meet the demand for additional programming, statistical and medical writing resource.

Objectives and Key Challenges

The client experienced a substantial demand for additional programming resources and an unpredictable requirement for statistical analysis expertise and medical writing capabilities. Changes in resourcing meant that the company decided to outsource in order to tackle the following challenges:

Difficulties in managing capacity and ensuring quick turnaround times due to unanticipated peaks and troughs in the workload.
Lack of adequate internal resourcing to meet demands.
Office space limitations at the client’s site which was inhibiting growth and recruitment.
A constant need to keep cost structures optimal, meaning long lead times were not feasible.

Facing fluctuating workloads and limited internal capacity?

Discover how our biostatistics and programming specialists can help you improve efficiency, maintain quality, and keep delivery on track. Contact us today.

Speak to our data experts

Strategic Approach and Tailored Solutions

Quanticate developed a tailored solution to deliver a flexible and cost-efficient service that effectively met our client’s needs. This included:

Establishing a dedicated office within five miles of the client’s site. This team was overseen and coordinated by a dedicated Quanticate program manager and provided prompter support. This including scaling up the project team quickly to accommodate an increase in workload.
Rapid rump up of resources: adoption of an FSP model in 2011 and the outsourcing of 40 full-time equivalents (FTEs). The relationship has gone from strength to strength over the years, with a rapid growth of FTEs to more than 80 in 2018, and up to 230 for 2020 and future studies.
Developing appropriate standard operating procedures (SOPs) that were suitable for the project strategy. This was supported by the creation and implementation of a requirement-specific training program delivered by the client to ensure the Quanticate team could operate as an extension of its internal team
Creation of our own extensive training documentation to help with the on-boarding of new team members. This included ‘super users’, who were experts in the client systems who were the first point of contact for questions and support.
Our resources and services aligned to client objectives, systems and measurements.
We incorporated a team bonus system linked to the client’s standards and structure to ensure our resources were aligned to the clients preferred working style. This created a greater sense of collaboration and working as part of the same team and not as an independent service provider.

Successful Client Outcomes

The success of this project and the long-term partnership has been characterized by a number of added-value benefits and key results, including:

Resource flexibility including the availability of trained staff at the client site at short notice.
Improved communication due to proximity to the client’s clinical team.
Improved timelines on client deliverables.
'Quality and on-time deliveries' metrics improvements:

Quality and on-time deliveries metrics 2015 - 2019
Greater efficiencies with a 30% reduction in the client’s cost of clinical studies.
Ability to use optimal cost locations such as the opening of an office in mainland Europe to provide additional resource, coupled with on-site and local experts to add value to the clinical teams.
Reduced overhead costs and minimized risks associated with peaks and troughs in workload.
Reduction in training requirements for the client as they were able to utilize the Quanticate team and their expertise, as well as incorporating Quanticate’s training systems into their own training processes.
Reduction in client project management of studies and client oversight as this was provided by Quanticate, which supported an improvement in overall efficiencies as the client was able to allocate their own resources to other projects.
Reduced office crowding.
Lower recruitment and HR costs.
The reduction of contracts with multiple parties as the client no longer relied on using single statisticians and programmers. This lead to cost savings as premium contractor rates was avoided, and brought efficiencies to the client as Quanticate acted as a single data-focused CRO and all governance and project management of data related services was placed with a single provider.
The client received consistent pricing by working with one vendor for data related services and not multiple vendors with their various pricing.

Conclusion

By implementing a scalable FSP model tailored to the client’s operational needs, Quanticate provided the flexible biostatistics, programming, and medical writing support required to manage fluctuating workloads without compromising quality or speed. Through close alignment with the client’s teams, processes, and performance standards, the partnership delivered measurable improvements in communication, turnaround times, and delivery metrics, while also reducing oversight burden and operating costs. The result was a more efficient, integrated resourcing model that not only supported immediate study demands, but also created a strong foundation for long-term growth and a significant reduction in the overall cost of clinical studies.

Biostatistics and Programming

A Functional Service Provision (FSP) Case Study with a Top 5 Pharmaceutical.